This observational study will collect blood and urine and clinical information from individuals with early-stages of polycystic kidney disease (PKD), their unaffected siblings and normal volunteers to create a biobank, also called a biorepository. The long-term goal is to develop new knowledge on biological markers or biomarkers that indicate changes in the disease progression. An understanding of biomarkers for early renal cyst growth will benefit PKD patients as new therapies are being developed and tested.
Polycystic Kidney Disease
This observational study will collect blood and urine and clinical information from individuals with early-stages of polycystic kidney disease (PKD), their unaffected siblings and normal volunteers to create a biobank, also called a biorepository. The long-term goal is to develop new knowledge on biological markers or biomarkers that indicate changes in the disease progression. An understanding of biomarkers for early renal cyst growth will benefit PKD patients as new therapies are being developed and tested.
Early PKD Observational Cohort Study
-
University of Chicago, Chicago, Illinois, United States, 60637
University of Kansas Medical Center, Kansas City, Kansas, United States, 66160
Children's Mercy Hospital, Kansas City, Missouri, United States, 64108
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
4 Years to 35 Years
ALL
Yes
University of Kansas Medical Center,
Alan SL Yu, MD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center
Darren P Wallace, PhD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center
2025-06